MicroRNAs in rheumatoid arthritis

The role of genetic and epigenetic factors in the development of rheumatic diseases has been an interesting field of research over the past decades all around the world. Research on the role of microRNAs (miRNAs) in rheumatoid arthritis (RA) has been active and ongoing, and investigations have attem...

Full description

Saved in:
Bibliographic Details
Published in:Clinical rheumatology 2015-04, Vol.34 (4), p.615-628
Main Authors: Salehi, Eisa, Eftekhari, Rahil, Oraei, Mona, Gharib, Alvand, Bidad, Katayoon
Format: Article
Language:English
Subjects:
Anti-Inflammatory Agents - therapeutic use
Arthritis, Rheumatoid - genetics
Arthritis, Rheumatoid - metabolism
Autoimmune Diseases - metabolism
Biomarkers - metabolism
Gene Expression Regulation
Humans
Immune System
Inflammation
Medicine
Medicine & Public Health
MicroRNAs - metabolism
Multigene Family
Prognosis
Review Article
Rheumatology
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The role of genetic and epigenetic factors in the development of rheumatic diseases has been an interesting field of research over the past decades all around the world. Research on the role of microRNAs (miRNAs) in rheumatoid arthritis (RA) has been active and ongoing, and investigations have attempted to use miRNAs as biomarkers in disease diagnosis, prognosis, and treatment. This review focuses on experimental researches in the field of miRNAs and RA to present the data available up to this date and includes researches searched by keywords “microRNA” and “rheumatoid arthritis” in PubMed from 2008 to January 2015. All references were also searched for related papers. miRNAs are shown to act as proinflammatory or anti-inflammatory agents in diverse cell types, and their role seems to be regulatory in most instances. Researchers have evaluated miRNAs in patients compared to controls or have investigated their role by overexpressing or silencing them. Multiple targets have been identified in vivo, in vitro, or in silico, and the researches still continue to show their efficacy in clinical settings.
ISSN:0770-3198
1434-9949
DOI:10.1007/s10067-015-2898-x